Context Therapeutics (CNTX) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.1
-0.08
-0.05
-0.03

Details

Expected EPS
-0.0875
Actual EPS
-0.1
Surprise EPS
-0.01
Surprise Percent
+14.29%

Description

Context Therapeutics (CNTX) has reported earnings of -0.1 per share for Q4 2025.

0 Comments

Share your thoughts